Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies
Year: 2014
Type: article
Abstract: Increased understanding of intertumoral heterogeneity at the genomic level has led to significant advancements in the treatment of solid tumors. Functional genomic alterations conferring sensitivity to targeted therapies can take many forms, and appropriate methods and tools are needed to detect these alterations. This review provides an update on genetic variability among solid tumors of similar histologic classification, using non-small cell lung cancer and melanoma as examples. We also discuss relevant technological platforms for discovery and diagnosis of clinically actionable variants and highlight the implications of specific genomic alterations for response to targeted therapy.
Source: Clinical Cancer Research
Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Awards: G153582612, G1827975024, G1949395773, G2065572564, G2146954135, G2684890037, G290007438, Overcoming acquired resistance to EGFR inhibitors in lung cancer, Medical Scientist Training Program, G4342453648, G435997112, G457800531, Evolutionary Dynamics of Brain, Lung, and Hematopoietic Tumors, G725763919, G771694649, Vanderbilt Clinical Oncology Research Career Development Award
OpenAlex ID: W2102007289
